Literature DB >> 15652199

Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.

Dongjie Huo1, Shuhai Deng, Lingbing Li, Jianbo Ji.   

Abstract

Lung-targeting cisplatin-loaded poly(lactic-co-glycolic) acid microspheres (CDDP-PLGA-MS) were prepared by a solvent evaporation method. The uniform design was used to optimize the technology of preparation, the appearance and size distribution were examined by scanning electron microscope, and the aspects such as in vitro release characteristics, stability, drug loading, loading efficiency, pharmacokinetics and tissue distribution in rabbit were studied. The experimental results showed that the microspheres were globular in appearance and dispersed well. The average particle size was 12.8 microm with 98% of the microspheres being in the range of 5-30 microm. The drug loading and loading efficiency were 17.68 and 53.2%, respectively. The in vitro release behavior could be expressed by the following equation: 1-Q=0.424e(-0.360t)+0.474e(-0.001t). After i.v. administration (15 min), the drug concentration of microspheres group in lung in rabbits was 212 microg/g, while that of controlled group was 1.37 microg/g. CDDP-PLGA-MS showed a combination of lung-targeting and sustained drug release in experiments on rabbits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652199     DOI: 10.1016/j.ijpharm.2004.10.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Fabrication of cisplatin-loaded poly(lactide-co-glycolide) composite microspheres for osteosarcoma treatment.

Authors:  Yan Li; Sierin Lim; Chui Ping Ooi
Journal:  Pharm Res       Date:  2011-10-07       Impact factor: 4.200

2.  Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier.

Authors:  Tetsuya Ozeki; Shuji Beppu; Takuto Mizoe; Yuuki Takashima; Hiroshi Yuasa; Hiroaki Okada
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

3.  Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers.

Authors:  Laura T Ferguson; Elizabeth D Hood; Tea Shuvaeva; Vladimir V Shuvaev; Maria C Basil; Zhicheng Wang; Jia Nong; Xiaonan Ma; Jichuan Wu; Jacob W Myerson; Oscar A Marcos-Contreras; Jeremy Katzen; Justine M Carl; Edward E Morrisey; Edward Cantu; Carlos H Villa; Samir Mitragotri; Vladimir R Muzykantov; Jacob S Brenner
Journal:  ACS Nano       Date:  2022-03-10       Impact factor: 18.027

4.  Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation.

Authors:  Weijun Wu; Jing Li; Lin Wu; Baoyan Wang; Zhongyuan Wang; Qunwei Xu; Hongliang Xin
Journal:  AAPS PharmSciTech       Date:  2013-06-29       Impact factor: 3.246

5.  Passive targeting and lung tolerability of enoxaparin microspheres for a sustained antithrombotic activity in rats.

Authors:  Shaimaa S Ibrahim; Rihab Osman; Nahed D Mortada; Ahmed-Shawky Geneidy; Gehanne A S Awad
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 6.  Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.

Authors:  Melissa Howard; Blaine J Zern; Aaron C Anselmo; Vladimir V Shuvaev; Samir Mitragotri; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2014-05-07       Impact factor: 15.881

7.  Nanomicelle-Microsphere Composite as a Drug Carrier to Improve Lung-Targeting Specificity for Lung Cancer.

Authors:  Qianqian Zhang; Jianwei Bao; Tijie Duan; Minxing Hu; Yuting He; Junwei Wang; Rongfeng Hu; Jihui Tang
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.